New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus

被引:109
作者
Pernow, John [1 ]
Shemyakin, Alexey [1 ]
Bohm, Felix [1 ]
机构
[1] Karolinska Univ Hosp, Dept Med, Cardiol Unit, Karolinska Inst, S-17176 Stockholm, Sweden
关键词
Endothelium; Vasoconstriction; Inflammation; Oxidative stress; Receptors; Glucose; Insulin resistance; INSULIN-RECEPTOR SUBSTRATE-1; NITRIC-OXIDE SYNTHASE; HUMAN CORONARY-ARTERY; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; ETA-RECEPTOR; ENDOGENOUS ENDOTHELIN; SUPEROXIDE-PRODUCTION; GLUCOSE-UPTAKE;
D O I
10.1016/j.lfs.2012.03.029
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endothelin-1 (ET-1) is a vasoconstrictor, proinflammatory and proliferative endothelial cell-derived peptide that is of significant importance in the regulation of vascular function. It is involved in the development of endothelial dysfunction including important interactions with nitric oxide. The expression and functional effects of ET-1 and its receptors are markedly altered during development of cardiovascular disease. Increased production of ET-1 and its receptors mediate many pathophysiological events contributing to the development of atherosclerosis and vascular complications in diabetes mellitus. The present review focuses on the pathophysiological role of ET-1 and the potential importance of ET receptors as a therapeutic target for treatment of these conditions. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:507 / 516
页数:10
相关论文
共 136 条
[1]  
Adlbrecht C, 2010, EUR HEART J, V31, P892
[2]   Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans [J].
Ahlborg, G ;
Lindström, J .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 93 (06) :2112-2121
[3]   Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease [J].
Ahlborg, Gunvor ;
Shemyakin, Alexey ;
Bohm, Felix ;
Gonon, Adrian ;
Pernow, John .
DIABETES CARE, 2007, 30 (03) :591-596
[4]   Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction [J].
Amiri, F ;
Virdis, A ;
Neves, MF ;
Iglarz, M ;
Seidah, NG ;
Touyz, RM ;
Reudelhuber, TL ;
Schiffrin, EL .
CIRCULATION, 2004, 110 (15) :2233-2240
[5]   Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation [J].
Anggrahini, Dyah W. ;
Emoto, Noriaki ;
Nakayama, Kazuhiko ;
Widyantoro, Bambang ;
Adiarto, Suko ;
Iwasa, Naoko ;
Nonaka, Hidemi ;
Rikitake, Yoshiyuki ;
Kisanuki, Yaz Y. ;
Yanagisawa, Masashi ;
Hirata, Ken-ichi .
CARDIOVASCULAR RESEARCH, 2009, 82 (01) :143-151
[6]   Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation [J].
Babaei, S ;
Picard, P ;
Ravandi, A ;
Monge, JC ;
Lee, TC ;
Cernacek, P ;
Stewart, DJ .
CARDIOVASCULAR RESEARCH, 2000, 48 (01) :158-167
[7]   Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta [J].
Bacon, CR ;
Cary, NR ;
Davenport, AP .
CIRCULATION RESEARCH, 1996, 79 (04) :794-801
[8]   Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL [J].
Ballinger, Mandy L. ;
Ivey, Melanie E. ;
Osman, Narin ;
Thomas, Walter G. ;
Little, Peter J. .
ATHEROSCLEROSIS, 2009, 205 (02) :451-457
[9]   INSULIN-MEDIATED SKELETAL-MUSCLE VASODILATION CONTRIBUTES TO BOTH INSULIN SENSITIVITY AND RESPONSIVENESS IN LEAN HUMANS [J].
BARON, AD ;
STEINBERG, HO ;
CHAKER, H ;
LEAMING, R ;
JOHNSON, A ;
BRECHTEL, G .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :786-792
[10]   Endothelin, hypercholesterolemia and atherosclerosis [J].
Barton, M ;
Traupe, T ;
Haudenschild, CC .
CORONARY ARTERY DISEASE, 2003, 14 (07) :477-490